Via Surgical, a Haifa, Israel-based developer of novel surgical fixation solutions, received an investment from Catcher Technology, an Asian manufacturing company listed on the Taiwan Stock Exchange.
The amount of the deal was not disclosed.
The new funding will be used to accelerate Via Surgical’s growth in the APAC region and will support development and production of its suture fixation system.
Led by Lena Levin, Co-Founder and CEO, Via Surgical provides the trademarked FasTouch™ deployable suture fixation system, which makes hernia repair surgeries less labor-intensive for surgeons and recovery less painful for patients. The company has secured two U.S. Food and Drug Administration 510(k) clearances for the FasTouch™ Absorbable and FasTouch™ Permanent Fixation Systems.
Founded in 2012, the company also has 16 issued patents in the US and worldwide, and 17 additional provisional patents filed in the US.